“menlo-therapeutics” Archives

in
Entry Author Date Location
Cara Therapeutics Itching Drug Scratches Off Goals of Phase 3 Test 04/21/20 New York
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Menlo’s Itching Drug Racks Up Two More Trial Failures, Program Ends 04/06/20 New York
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
With Foamix Merger Weeks Away, Menlo Itching Drug Fails a Phase 2 Test 02/26/20 San Francisco
Trevi Therapeutics Files for IPO to Fund Anti-Itching Drug R&D 04/08/19 New York
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Menlo’s Drug Fails Again in Clinical Trials, This Time for Chronic Cough 10/08/18 San Francisco
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
After Strong 2017, Biotechs & Medtechs Start ’18 with Venture, IPO News 01/02/18 National
Page 1 of 1